Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation, peak flow variability and quality of life in asthma patients

被引:101
作者
Porsbjerg, C. [1 ]
Brannan, J. D. [2 ]
Anderson, S. D. [3 ]
Backer, V. [1 ]
机构
[1] Univ Copenhagen Hosp, Resp Res Unit, Dept Resp Med, Bispebjerg Hosp, DK-2400 Copenhagen NV, Denmark
[2] McMaster Univ, St Josephs Hlth Ctr, Firestone Inst Resp Hlth, Hamilton, ON L8S 4L8, Canada
[3] Royal Prince Alfred Hosp, Dept Resp Med, Camperdown, NSW 2050, Australia
关键词
asthma; airway hyperresponsiveness; inflammation; mannitol; methacholine;
D O I
10.1111/j.1365-2222.2007.02878.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background Airway hyperresponsiveness (AHR) to stimuli that cause bronchial smooth muscle (BSM) contraction indirectly through the release of endogenous mediators is thought to reflect air-way inflammation more closely compared with AHR measured by stimuli that act directly on BSM. Methods Fifty-three adult non-smoking asthmatics (28 females, 18-56 years) who were not taking inhaled steroids were challenged with mannitol (up to 635 mg) and methacholine (up to 8 mu mol). Induced sputum eosinophils, exhaled nitric oxide (eNO), peak flow variation and clinical severity of asthma according to the Global Initiative for Asthma guidelines were measured in addition to the health-related quality-of-life score using the Juniper asthma quality-of-life questionnaire. Findings Both ABR to mannitol as well as to methacholine was associated with elevated markers of airway inflammation: in 83% of asthma patients with AHR to mannitol, and in 88% of asthma patients with AHR to methacholine, the eNO level was > 20 p.p.b. Sputum% eosinophils >1% was measured in 70% of asthma patients with AHR to mannitol and in 77% of asthma patients with AHR to methacholine. In asthma patients without AHR, 15% had an eNO level >20p.p.b., but none had sputum% eosinophils >1%. AHR to mannitol was more closely associated with the percentage of sputum eosinophils (PD15 to mannitol vs. sputum% eosinophils: r: -0.52, P<0.05), compared with AHR to methacholine (PD20 to methacholine vs. sputum% eosinophils: r: -0.28, NS). Furthermore, there was a stronger correlation between AHR to mannitol and the level of eNO [PD15 to mannitol vs. eNO (p.p.b.): r: -0.63, P <0.001], compared with AHR to methacholine [PD20 to methacholine vs. eNO (p.p.b.): r: -0.43, P<0.05]. Interpretation In asthma patients not being treated with steroids, AHR to mannitol and to methacholine indicated the presence of airway inflammation. AHR to mannitol reflected the degree of airway inflammation more closely when compared with methacholine.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 32 条
[1]   A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol [J].
Anderson, SD ;
Brannan, J ;
Spring, J ;
Spalding, N ;
Rodwell, LT ;
Chan, K ;
Gonda, I ;
Walsh, A ;
Clark, AR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (03) :758-765
[2]   Methods for "indirect" challenge tests including exercise, eucapnic voluntary hyperpnea, and hypertonic aerosols [J].
Anderson, SD ;
Brannan, JD .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2003, 24 (01) :27-54
[3]  
[Anonymous], 2006, AM J RESP CRIT CARE, V173, P811
[4]   The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline [J].
Brannan, JD ;
Anderson, SD ;
Perry, CP ;
Freed-Martens, R ;
Lassig, AR ;
Charlton, B .
RESPIRATORY RESEARCH, 2005, 6 (1)
[5]   Responsiveness to mannitol in asthmatic subjects with exercise- and hyperventilation-induced asthma [J].
Brannan, JD ;
Koskela, H ;
Anderson, SD ;
Chew, N .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (04) :1120-1126
[6]   Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing [J].
Brannan, JD ;
Gulliksson, M ;
Anderson, SD ;
Chew, N ;
Seale, JP ;
Kumlin, M .
EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (05) :944-950
[7]   Evidence of mast cell activation and leukotriene release after mannitol inhalation [J].
Brannan, JD ;
Gulliksson, M ;
Anderson, SD ;
Chew, N ;
Kumlin, M .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (03) :491-496
[8]   Mechanisms of airway hyperresponsiveness [J].
Cockcroft, Donald W. ;
Davis, Beth E. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (03) :551-559
[9]  
Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309
[10]   Effects of mediator antagonism on mannitol and adenosine monophosphate challenges [J].
Currie, GP ;
Haggart, K ;
Lee, DKC ;
Fowler, SJ ;
Wilson, AM ;
Brannan, JD ;
Anderson, SD ;
Lipworth, BJ .
CLINICAL AND EXPERIMENTAL ALLERGY, 2003, 33 (06) :783-788